Blog
How does AI-enabled causal modelling support discussions with potential investors?
02/10/2025
Welcome back to our blog series where we share some of the highlights and key takeaways from our fireside chat with CEO of Simbec-Orion, Fabrice Chartier, and CEO of biotx.ai, Joern Klinger. Our last blog post covered what AI-enabled causal modelling is, how it is different from other models, and where you might want to […]
Can early utilisation of AI-enabled causal modelling de-risk and accelerate clinical development?
02/10/2025
Can early utilisation of AI de-risk and accelerate clinical development for drug developers? Recent announcements suggest large pharma companies are betting big on AI. AstraZeneca recently announced a $247 million deal with an AI vendor to support identifying new oncology drug candidates[1]. Sanofi has announced a collaboration with two separate AI vendors, worth up to […]
The Impact of Clinical Trials on MS Research and Care
08/08/2025
Clinical trials are essential in advancing treatments for multiple sclerosis (MS). With no cure currently available, ongoing research is critical to uncovering new, more effective therapies. Simbec-Orion is a Clinical Research Organisation with nearly five decades of experience, specialising in oncology and rare diseases. This article explores the vital role that clinical trials play in […]
The Impact of Clinical Trials on Pneumonia
08/08/2025
Pneumonia is an infection of the respiratory system, resulting in inflammation of the alveoli, or air sacs, within your lungs. This causes symptoms like coughing, breathing problems, fatigue, a fever and more. Here at Simbec-Orion, we bring five decades of clinical research expertise, focused on rare diseases and oncology. What is Pneumonia? As a respiratory illness, […]
The Impact of Clinical Trials on Interstitial Lung Disease (ILD)
05/08/2025
Interstitial Lung Disease, otherwise known as ILD, is a grouping of rare lung conditions that currently have no known cure. With this in mind, clinical trials play a pivotal role in advancing knowledge and discovering more effective treatments.At Simbec-Orion, we bring nearly 50 years of experience as a Clinical Research Organisation focused on oncology and […]
What are Early Phase Clinical Trials?
05/08/2025
Phase I and Phase II clinical trials are the first stage of testing a new medical treatment, drug, or device in human subjects. The purpose of these early-stage trials is primarily to assess the safety, tolerability, and potential side effects of a new treatment. You may also be interested in exploring early-phase oncology trials or […]
The Importance of Clinical Trials in Research For COPD
29/07/2025
COPD has life-changing effects on millions of people worldwide, making it difficult to perform regular daily activities due to difficulty breathing. Despite existing treatments, COPD has debilitating consequences on everyday life and there is currently no cure. Here at Simbec-Orion, we are a specialist CRO company, helping manage clinical trials and drug development for many […]
